Chimeric Antigen Receptor CAR-T

In healthy patients T cells detect and kill sick cells. Cancer cells escape T cells recognition thanks to mutations. CAR-T cells (T cells equipped with a Chimeric Antigen Receptor) are artificially hardcoded to recognize and kill cancer cells. Multiple CAR-T therapies are commercially available but their access is limited by low manufacturing throughput and high prices. We use our exclusive optimization and miniaturization technologies to improve CAR-T therapies in clinically validated applications to boost their accessibility.